Latest Breaking News On - Ciron drugs - Page 3 : comparemela.com

Share this article Share this article ResearchAndMarkets.com s offering. In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021-2026. The global IV and oral iron drugs market is expected to grow due to the prevalence of iron deficiency (ID). This deficiency is a highly widespread nutritional disorder, affecting around one-fourth of the global population, especially women and children. It is one of the predominant causes of anemia. Anemia accounts for around 9% of the total global disease burden. Several chronic diseases are frequently associated with iron deficiency anemia (IDA) such as chronic kidney disease (CKD), chronic heart failure, cancer, and inflammatory bowel diseases. As anemia is associated with chronic fatigue, diminished well-being, and impaired cognitive function, the treatment

United statesUnited kingdomSouth africaSaudi arabiaSouth koreaVifor pharmaLaura woodCombination dietary supplements nutritional health productsDaiichi sankyo companyCiron drugs pharmaceuticalsOffice hours callResearch methodologyAdministration segmentationPatient groupKey company profilesE st office hours call